150 related articles for article (PubMed ID: 37121475)
1. Prevalence of polycystic ovarian syndrome among children and adolescents with hidradenitis suppurativa.
Mastacouris N; Strunk A; Garg A
J Am Acad Dermatol; 2023 Aug; 89(2):425-427. PubMed ID: 37121475
[No Abstract] [Full Text] [Related]
2. Hidradenitis suppurativa and polycystic ovarian syndrome: Systematic review and meta-analysis.
Phan K; Charlton O; Smith SD
Australas J Dermatol; 2020 Feb; 61(1):e28-e33. PubMed ID: 31261440
[TBL] [Abstract][Full Text] [Related]
3. Hidradenitis suppurativa and polycystic ovary syndrome: analysis of demographics in the inpatient setting.
Singal A; Choudhry HS; Desai AD; Lipner SR
Arch Dermatol Res; 2023 Nov; 316(1):4. PubMed ID: 37982912
[No Abstract] [Full Text] [Related]
4. Pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) and polycystic ovary syndrome: Coincidentally or aetiologically connected?
Zivanovic D; Masirevic I; Ruzicka T; Braun-Falco M; Nikolic M
Australas J Dermatol; 2017 May; 58(2):e54-e59. PubMed ID: 26831949
[TBL] [Abstract][Full Text] [Related]
5. Hidradenitis Suppurativa Is Associated with Polycystic Ovary Syndrome: A Population-Based Analysis in the United States.
Garg A; Neuren E; Strunk A
J Invest Dermatol; 2018 Jun; 138(6):1288-1292. PubMed ID: 29378201
[TBL] [Abstract][Full Text] [Related]
6. Overall and subgroup prevalence of acne vulgaris among patients with hidradenitis suppurativa.
Wertenteil S; Strunk A; Garg A
J Am Acad Dermatol; 2019 May; 80(5):1308-1313. PubMed ID: 30287328
[TBL] [Abstract][Full Text] [Related]
7. Endocrinologic Aspects of Hidradenitis Suppurativa.
Karagiannidis I; Nikolakis G; Zouboulis CC
Dermatol Clin; 2016 Jan; 34(1):45-9. PubMed ID: 26617357
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.
Gold DA; Reeder VJ; Mahan MG; Hamzavi IH
J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of depression among children, adolescents, and adults with hidradenitis suppurativa.
Wright S; Strunk A; Garg A
J Am Acad Dermatol; 2022 Jan; 86(1):55-60. PubMed ID: 34144081
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.
Garg A; Malviya N; Strunk A; Wright S; Alavi A; Alhusayen R; Alikhan A; Daveluy SD; Delorme I; Goldfarb N; Gulliver W; Hamzavi I; Jaleel T; Kimball AB; Kirby JS; Kirchhof MG; Lester J; Lev-Tov H; Lowes MA; Micheletti R; Orenstein LA; Piguet V; Sayed C; Tan J; Naik HB
J Am Acad Dermatol; 2022 May; 86(5):1092-1101. PubMed ID: 33493574
[TBL] [Abstract][Full Text] [Related]
11. Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 2.
Vekic DA; Cains GD
Australas J Dermatol; 2018 Nov; 59(4):261-266. PubMed ID: 29363099
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological, clinical and therapeutic aspects in special situations: hidradenitis suppurativa in paediatric patients.
Rodríguez Bandera A; de Lucas Laguna R
Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():51-60. PubMed ID: 28081770
[TBL] [Abstract][Full Text] [Related]
13. Hidradenitis Suppurativa in Pediatric Patients.
Cotton CH; Chen SX; Hussain SH; Lara-Corrales I; Zaenglein AL
Pediatrics; 2023 May; 151(5):. PubMed ID: 37102307
[TBL] [Abstract][Full Text] [Related]
14. Association between obesity and hidradenitis suppurativa among children and adolescents: A population-based analysis in the United States.
Balgobind A; Finelt N; Strunk A; Garg A
J Am Acad Dermatol; 2020 Feb; 82(2):502-504. PubMed ID: 31442534
[No Abstract] [Full Text] [Related]
15. Prevalence and Description of Hidradenitis Suppurativa in Down Syndrome: A Cross-sectional Study of 783 Subjects.
Poizeau F; Sbidian E; Mircher C; Rebillat AS; Chosidow O; Wolkenstein P; Ravel A; Hotz C
Acta Derm Venereol; 2019 Mar; 99(3):351-352. PubMed ID: 30460373
[No Abstract] [Full Text] [Related]
16. Which hidradenitis suppurativa comorbidities should I take into account?
Tzellos T; Zouboulis CC
Exp Dermatol; 2022 Sep; 31 Suppl 1():29-32. PubMed ID: 35737874
[TBL] [Abstract][Full Text] [Related]
17. Gynecologic and andrologic dermatology and the metabolic syndrome.
Roth MM; Leader N; Kroumpouzos G
Clin Dermatol; 2018; 36(1):72-80. PubMed ID: 29241756
[TBL] [Abstract][Full Text] [Related]
18. Hidradenitis suppurativa: current progress and future questions.
Pascoe VL; Kimball AB
JAMA Dermatol; 2014 Dec; 150(12):1263-4. PubMed ID: 25229429
[No Abstract] [Full Text] [Related]
19. Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice.
Prens EP; Lugo-Somolinos AM; Paller AS; Kerdel F; Duan Y; Teixeira HD; Longcore M; Kimball AB
Am J Clin Dermatol; 2020 Aug; 21(4):579-590. PubMed ID: 32077014
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of metabolic syndrome in patients of south of Brazil with polycystic ovary syndrome (PCOS)].
Spritzer PM; Wiltgen D
Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):146-7. PubMed ID: 17435870
[No Abstract] [Full Text] [Related]
[Next] [New Search]
